NDMA Impurity Detection in Sartan APIs via GC-MS Headspace Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of antihypertensive drugs containing the biphenyltetrazolium group, such as Losartan and Irbesartan, often results in the production of toxic N-nitrosodimethylamine (NDMA) impurity due to the decomposition of N,N-dimethylformamide (DMF) solvent, which is challenging to detect and control, especially at trace levels.
Innovation Solution
A method using gas chromatography-mass spectrometry (GC-MS) to detect trace N-nitrosodimethylamine (NDMA) impurity in sartan API products and their synthesis solvents, involving the preparation of a test solution by dissolving the sample in a diluent and analyzing it directly in an injection vial or headspace bottle, with standard curve determination for quantification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If gas chromatography-mass spectrometry is used to detect trace NDMA impurity, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent uses a headspace bottle as an intermediary device between the sample and the GC-MS instrument. The headspace bottle allows trace NDMA to be extracted and concentrated from the complex matrix, serving as a mediator that simplifies the analysis while maintaining high detection sensitivity. This resolves the contradiction by providing a simple sample preparation step that works effectively with the sophisticated GC-MS instrumentation.
2Productivity
If direct injection method is used for solvent samples, then productivity is improved, but measurement precision may deteriorate
Solution Approach 1:
The patent implements a dynamic detection strategy where the injection method is automatically adjusted based on the sample type. For solvent samples, direct injection is used to maximize productivity. For complex matrices like API products, headspace extraction is employed to ensure measurement precision. This dynamic adaptation resolves the contradiction by optimizing both speed and accuracy according to specific analytical needs.
3Object-affected harmful factors
If trace NDMA impurity is produced due to DMF decomposition, then harmful factors increase, but detection becomes more challenging
Solution Approach 1:
The patent exploits the phase transition properties of NDMA by using headspace extraction, where NDMA in the liquid phase is transferred to the gas phase. This phase transition concentrates the trace impurity and separates it from the liquid matrix, making the highly toxic but difficult-to-detect NDMA measurable by GC-MS. The phase transition thus resolves the detection difficulty while the sensitive detection method addresses the harmful factor.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a sensitive and effective means to detect NDMA impurity at trace levels, ensuring quality control of sartan API products and solvents, with a wide linear range and good separation effects, enabling quick and accurate detection of NDMA content.
Implementation Method 1
analyzing the solution in the injection vial or headspace bottle by gas chromatography-mass spectrometry
Implementation Method 2
analyzing the solution in the injection vial or headspace bottle by gas chromatography-mass spectrometry
Data Source
Figure 1
AI summary
Disclosed is a detection method for N-nitrosodimethylamine (NDMA) impurities, comprising: (1) obtaining a test solution containing a sample to be tested; and (2) detecting the test solution by means of gas chromatography-mass spectrometry to determine the content of an N-nitrosodimethylamine impurity in the sample. The method provided in the present invention has a good separating effect, a wide linear range, a high sensitivity and a good method durability, and can detect the content of N-nitrosodimethylamine (NDMA) in the sample rapidly and effectively.